https://scholars.lib.ntu.edu.tw/handle/123456789/565029
標題: | Induced pluripotent stem cell technology for disease modeling and drug screening with emphasis on lysosomal storage diseases | 作者: | HSIANG-PO HUANG Chuang C.-Y. Kuo H.-C. |
公開日期: | 2012 | 卷: | 3 | 期: | 4 | 來源出版物: | Stem Cell Research and Therapy | 摘要: | The recent derivation of disease-specific induced pluripotent stem cells (iPSCs) from somatic cells of patients with familial and sporadic forms of diseases and the demonstration of their ability to give rise to disease-relevant cell types provide an excellent opportunity to gain further insights into the mechanisms responsible for the pathophysiology of these diseases and develop novel therapeutic drugs. Here, we review the recent advances in iPSC technology for modeling of various lysosomal storage diseases (LSDs) and discuss possible strategies through which LSD-iPSCs can be exploited to identify novel drugs and improve future clinical treatment of LSDs. ? 2012 BioMed Central Ltd. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-84865785106&doi=10.1186%2fscrt125&partnerID=40&md5=26b6a2bc79ea29b0ece5698e8f1f0a71 https://scholars.lib.ntu.edu.tw/handle/123456789/565029 |
ISSN: | 1757-6512 | DOI: | 10.1186/scrt125 | SDG/關鍵字: | agalsidase alfa; galsulfase; iduronate 2 sulfatase; laronidase; mercaptamine; miglustat; recombinant glucan 1,4 alpha glucosidase; sphingomyelin phosphodiesterase; carcinogenesis; cell differentiation; Chediak Higashi syndrome; cystinosis; drug efficacy; drug safety; drug screening; enzyme replacement; Fabry disease; fucosidosis; Gaucher disease; globoid cell leukodystrophy; glycogen storage disease type 2; graft rejection; high throughput screening; human; Hunter syndrome; Hurler syndrome; immunogenicity; lysosome storage disease; metachromatic leukodystrophy; mucolipidosis type 2; mucopolysaccharidosis type 7; neuronal ceroid lipofuscinosis; Niemann Pick disease; nonhuman; pluripotent stem cell; priority journal; protein homeostasis; review; Sanfilippo syndrome; somatic cell; teratoma; animal; biological therapy; cytology; disease model; fibroblast; Lysosomal Storage Diseases; pluripotent stem cell; transplantation; Animals; Cell- and Tissue-Based Therapy; Disease Models, Animal; Enzyme Replacement Therapy; Fibroblasts; Humans; Induced Pluripotent Stem Cells; Lysosomal Storage Diseases |
顯示於: | 基因體暨蛋白體醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。